Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Revolade eltrombopag us market launch date?

See the DrugPatentWatch profile for eltrombopag

When did Revolade (eltrombopag) first launch in the US?

Revolade (eltrombopag) was launched in the United States in 2008. [1]

How to interpret “market launch date” (FDA approval vs. when pharmacies could sell it)

For drugs like Revolade, the FDA’s approval date and the actual market availability date can differ slightly. The launch timing can depend on initial distribution, labeling, and rollout after approval. The available US market launch information places Revolade’s entry in 2008. [1]

What year did it become available, and where can I verify?

If you need the specific US timing reference tied to market entry (often summarized alongside exclusivity/patent context), you can check the drug’s details on DrugPatentWatch.com. [1]

Sources
[1] https://www.drugpatentwatch.com/ ? (Revolade/eltrombopag listing; US market launch year shown as 2008)



Other Questions About Eltrombopag :

Eltrombopag patent expiry date? Eltrombopag patent expiry date china? Eltrombopag?